The oral, once-daily EGFR inhibitor is now in specialty distribution for patients whose disease progressed after platinum-based chemotherapy.
Feature|Articles|July 24, 2026
Nurses Lead the Way in the New Era of Chronic Lung Cancer Care
Author(s)Alex Biese
Fact checked by: Tracy Ann Politowicz
Oncology nurses discuss managing lung cancer as a chronic disease, addressing long-term symptoms, financial toxicity, and psychosocial care.
Advertisement
Advertisement
When Beth Sandy, CRNP, started her career at the Abramson Cancer Center at the University of Pennsylvania 23 years ago, the clinical landscape for lung cancer was a stark contrast to the modern era. "I’ve seen a lot in lung cancer from the start when we only had just a couple of drugs," Sandy recalls.
Related to this article
Following WCLC 2026, Katherine Kuhns details how perioperative immunotherapy, AI patient tools, and wearables are transforming thoracic surgical nursing care.
Brianne Whitley, CNP, of Dana-Farber, shares strategies for hot flashes, sexual health, survivorship planning, and clinical trial access for men.
The approval covers IV and subcutaneous pembrolizumab and raises the TMB-H threshold from 10 to 13 mutations/megabase.
Explore how nurses support kidney transplant candidates diagnosed with renal cell carcinoma, covering early detection, treatment options, and care.
Dana-Farber's Brianne Whitley, CNP, details red-flag symptoms, ER-positive biology, and why every man with breast cancer needs a genetic referral.
European survey reveals how oncology nurses manage complex multiple myeloma care amid time and resource constraints.
Leslie Smith, DNP, discusses mediating trial care, vetting protocols for nursing scope of practice, and guiding frontline nurses toward research.
Advertisement
Advertisement